Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MIF | P14174 | 4/20 | 0.64 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.50 |
| ▸ | IDO1 | P14902 | 2/20 | 0.50 |
| ▸ | AGXT | P21549 | 2/20 | 0.50 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.47 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.47 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.47 |
| ▸ | CMA1 | P23946 | 1/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.45 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.45 |
| ▸ | MAOB | P27338 | 1/20 | 0.45 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.45 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.45 |
| ▸ | CTBP2 | P56545 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4672 | 0.83 | TAAR1 (0.50) | TAAR1IDO1AGXTCHRM2CHRM1 | |
| SCHEMBL9490171 | 0.81 | TAAR1 (0.60) | TAAR1IDO1AGXTCHRM2CHRM1 | |
| SCHEMBL483536 | 0.81 | MIF (0.74) | MIFTRPA1ALDH1A1CYP3A4HPGD | |
| SCHEMBL10666513 | 0.80 | MIF (0.50) | MIFTRPA1ALDH1A1CYP3A4HPGD | |
| SCHEMBL13664654 | 0.79 | MIF (0.60) | MIFTRPA1ALDH1A1CYP3A4HPGD | |
| SCHEMBL3004829 | 0.78 | TAAR1 (0.56) | ALDH1A1TAAR1IDO1AGXTCHRM2 | |
| SCHEMBL354853 | 0.78 | MIF (1.00) | MIFTRPA1ALDH1A1CYP3A4HPGD | |
| SCHEMBL19994035 | 0.77 | MIF (0.48) | MIFTRPA1ALDH1A1CYP3A4HPGD | |
| SCHEMBL30207605 | 0.77 | MIF (0.48) | MIFTRPA1ALDH1A1CYP3A4HPGD | |
| SCHEMBL10651510 | 0.77 | MIF (0.62) | MIFTRPA1ALDH1A1CYP3A4HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250228757-A1 | SUNSCREEN COMPOUNDS AND FORMULATIONS | OREGON STATE UNIVERSITY (US) | 2025-07-17 | — | — | US | claimed |
| CN-107840850-A | One kind (±) macahydantoin revised B scale synthesis preparation method | 云南民族大学 | 2018-03-27 | — | — | CN | claimed |
| US-20250228757-A1 | SUNSCREEN COMPOUNDS AND FORMULATIONS | OREGON STATE UNIVERSITY (US) | 2025-07-17 | — | — | US | disclosed |
| WO-2025105873-A1 | EASILY INSERTABLE AND REMOVABLE MENSTRUAL CUP FOR PREVENTING COLORING | 주식회사 올담 | 2025-05-22 | — | — | WO | disclosed |
| US-20250066293-A1 | OIL-BASED ISOTHIOCYANATE PRODUCTS AND PROCESSES FOR PREPARING OIL-BASED ISOTHIOCYANATE PRODUCTS | BRASSICA PROTECTION PRODUCTS LLC (US) | 2025-02-27 | — | — | US | disclosed |
| WO-2023133494-A2 | OIL-BASED ISOTHIOCYANATE PRODUCTS AND PROCESSES FOR PREPARING OIL-BASED ISOTHIOCYANATE PRODUCTS | BRASSICA PROTECTION PRODUCTS LLC (US) | 2023-07-13 | — | — | WO | disclosed |
| US-20190046530-A1 | PHASE 2 INDUCERS AND RELATED SIGNALING PATHWAYS PROTECT CARTILAGE AGAINST INFLAMMATION, APOPTOSIS AND STRESS | KONSTANTOPOULOS KONSTANTINOS (US) | 2019-02-14 | — | — | US | disclosed |
| CN-107840850-A | One kind (±) macahydantoin revised B scale synthesis preparation method | 云南民族大学 | 2018-03-27 | — | — | CN | disclosed |
| US-20160038485-A1 | PHASE 2 INDUCERS AND RELATED SIGNALING PATHWAYS PROTECT CARTILAGE AGAINST INFLAMMATION, APOPTOSIS AND STRESS | TALALAY, PAUL | 2016-02-11 | — | — | US | disclosed |
| US-20160038485-A1 | PHASE 2 INDUCERS AND RELATED SIGNALING PATHWAYS PROTECT CARTILAGE AGAINST INFLAMMATION, APOPTOSIS AND STRESS | TALALAY, PAUL | 2016-02-11 | — | — | US | disclosed |
| US-8784856-B2 | Meadowfoam-based bioherbicide products | The State of Oregon Acting by and Through the State Boad of Higher Education on Behalf of Oregon State University (US) | 2014-07-22 | — | — | US | disclosed |
| US-20010056205-A1 | 3-Methoxybenzyl thiourea derivatives and improved lipid compositions containing same | THE FANNING CORPORATION | 2001-12-27 | — | — | US | disclosed |
| US-6323223-B1 | CCR-3 RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, METHODS FOR THEIR USE AND METHODS FOR PREPARING THESE COMPOUNDS. | SYNTEX (U.S.A.) LLC | 2001-11-27 | — | — | US | disclosed |
| EP-1155677-A2 | Methods and compositions for inhibiting free radical polymerization in skin and hair | Fan Tech Ltd. (US) | 2001-11-21 | — | — | EP | disclosed |
| WO-2001085681-A2 | 3-METHOXYBENZYL THIOUREA DERIVATIVES AND IMPROVED LIPID COMPOSITIONS CONTAINING SAME | THE FANNING CORPORATION (US) | 2001-11-15 | — | — | WO | disclosed |
| US-6194438-B1 | ANTITUMOR AGENTS; ANTICANCER AGENTS; FARNESYL-PROTEIN TRANSFERASE INHIBITOR | PFIZER INC. | 2001-02-27 | — | — | US | disclosed |
| EP-1006113-A1 | Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one and their use to inhibit abnormal cell growth | Pfizer Products Inc. (US) | 2000-06-07 | — | — | EP | disclosed |
| EP-0903349-A2 | CCR-3 receptor antagonists | F. HOFFMANN-LA ROCHE AG (CH) | 1999-03-24 | — | — | EP | disclosed |
| US-4761415-A | HYPOTENSIVE | SMITHKLINE BECKMAN CORPORATION (US) | 1988-08-02 | — | — | US | disclosed |
| EP-0261804-A1 | Dopamine-beta-hydroxylase inhibitors | SMITHKLINE BEECHAM CORPORATION (US) | 1988-03-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250228757-A1 | SUNSCREEN COMPOUNDS AND FORMULATIONS | ACSS2, FADS1, FADS2 | MIF 4441/4885TRPA1 455/4885ALDH1A1 189/4885 |
| US-20190046530-A1 | PHASE 2 INDUCERS AND RELATED SIGNALING PATHWAYS PROTECT CARTILAGE AGAINST INFLAMMATION, APOPTOSIS AND STRESS | PTGS2, PTGES2, CCAR2 | MIF 737/4885TRPA1 388/4885ALDH1A1 658/4885 |
| US-20010056205-A1 | 3-Methoxybenzyl thiourea derivatives and improved lipid compositions containing same | GPX4, LIPC, GPX1 | MIF 3173/4885TRPA1 2970/4885ALDH1A1 754/4885 |
| US-20160038485-A1 | PHASE 2 INDUCERS AND RELATED SIGNALING PATHWAYS PROTECT CARTILAGE AGAINST INFLAMMATION, APOPTOSIS AND STRESS | PTGS2, PTGES2, CCAR2 | MIF 737/4885TRPA1 388/4885ALDH1A1 658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.